Editor’s Choice for September 2018

Please rate this video

Please complete at least one question.

The information in this video was of interest to me Disagree Agree
The information in this video is likely to improve my clinical practice or research Disagree Agree
I would recommend this video to my colleagues Disagree Agree

Submit

Thanks for rating

There has been a problem, please refresh and try again.

Published: 28.09.18

Rating:

Shortlist Rate Video

Prof Gordon McVie - Founding Editor, ecancer

	Journal
	Special Issue: The microbiome – a novel paradigm in oncology research
	Conference Report: Highlights from the 2018 WIN Symposium, 25–26 June 2018, Paris: designing the future of precision oncology
	Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas
	Case Report: Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation
	Video
	WIN Symposium 2018
	R4HC
	Education
	Latin American Palliative Care Course

Complementary medicine · Nursing · Nutrition & wellbeing · Personalised medicine · Care · Economics · Global health & cancer · Low-middle income · Medicines · Organisation of cancer · Prevention · R&D · Regulatory · Science domains · Social determinants · Technology & innovation · Training & development · Biology · Biomarkers · Causes of cancer · Control, survivorships & outcomes · Detection, diagnosis & prognosis · Diagnostics · Epidemiology & prevention · Imaging · Screening · Antibodies & immunotherapy · Cell therapy & stem cells · Complications · Cytotoxics · Drug development · Targeted molecules